A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Clinical trial NCT05984147 · RECRUITING
Trial details
- NCT number
- NCT05984147
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2027-08-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.